| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 113824-76-3 | 2-(甲基(2-苯氧基乙基)氨基)乙醇 | 2-(methyl(2-phenoxyethyl)amino)ethanol | | | | |
| 1138245-13-2 | | mirogabalin | | | | |
| 113825-02-8 | 1-(呋喃-2-基甲基)-1,3-二氢-2h-咪唑-2-硫酮 | 1-(furan-2-ylmethyl)-1,3-dihydro-2h-imidazole-2-thione | | | | |
| 113825-16-4 | | 4-methyl-1h-imidazole-2-carboxaldehyde | | | | |
| 113825-82-4 | | 4) diazepin-2-yl)acetyl)--a)( | | | | |
| 113825-83-5 | | morpholine, 4-(4-(4-(2-chlorophenyl)-9-methyl-6h-thieno(3,2-f)(1,2,4)triazolo(4 | | | | |
| 113825-84-6 | | morpholine, 4-(5-(4-(2-chlorophenyl)-9-methyl-6h-thieno(3,2-f)(1,2,4)triazolo(4 | | | | |
| 113825-85-7 | | 6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine-2-acetamide, 4-(2-chloroph | | | | |
| 113825-86-8 | | 6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine-2-propanamide, n,n-bis(2-h | | | | |
| 113825-87-9 | | morpholine, 4-(3-(9-(chloromethyl)-4-(2-chlorophenyl)-6h-thieno(3,2-f)(1,4)tria | | | | |
| 113825-88-0 | | morpholine, 4-(3-(9-(bromomethyl)-4-(2-chlorophenyl)-6h-thieno(3,2-f)(1,2,4)tri | | | | |
| 113826-06-5 | (R)-对甲苯磺酸缩水甘油酯 | (R)-(-)-Glycidyl p-toluenesulfonate | C10H12O4S | 228.27 | 45-48℃ | |
| 113826-40-7 | 5-甲氧基哌啶-3-甲酸甲酯 | methyl 5-methoxypiperidine-3-carboxylate | | | | |
| 113826-44-1 | 头孢哌酮 二水合物 | cefoperazone dihydrate | | | | |
| 113826-87-2 | | (3-methyl-5-phenyl-isoxazol-4-yl)-methanol | | | | |
| 113826-88-3 | | n-2-pyridinyl-1h-benzimidazole-2-carboxamid | | | | |
| 113829-10-0 | | 1,2-dioleoyl-3-stearoyl-rac-glycerol | C57H106O6 | 887.46 | | |
| 113829-56-4 | | 4-(4-methyl-6-((methylthio)methyl)-2-morpholinyl)-1h-indol cis-(+-)-1h-indol (e)-2 | | | | |
| 1138324-46-5 | (2S,4R)-2-(氨基甲基)-4-氟吡咯烷-1-羧酸叔丁酯 | tert-butyl (2S,4R)-2-(aminomethyl)-4-fluoropyrrolidine-1-carboxylate | | | | |
| 1138324-48-7 | (2S,4R)-4-氟-2-(羟甲基)吡咯烷-1-羧酸叔丁酯 | (2S,4R)-tert-butyl 4-fluoro-2-(hydroxymethyl)pyrrolidine-1-carboxylate | | | | |
| 1138326-95-0 | 4-苯基-5-溴噻吩-2-甲醛 | 5-bromo-4-phenylthiophene-2-carbaldehyde | | | | |
| 113833-54-8 | | 1-naphthalenesulfonic acid, 4-hydroxy-3-[[4-[[[3-[[2-(sulfooxy)ethyl]sulfonyl]p | | | | |
| 113833-55-9 | | methanaminium, n-[4-[[4-(dimethylamino)phenyl][4-[(2-hydroxyethyl)amino]phenyl] | | | | |
| 1138331-79-9 | 1-(环丙氧基)-3,5-二氟苯 | 1-(cyclopropyloxy)-3,5-difluorobenzene | | | | |
| 1138331-90-4 | | 1-boc-3-(1-hydroxyethyl)-azetidine | | | | |
| 1138333-26-2 | | 4-bromo-2-(bromomethyl)thiazole | | | | |
| 113834-91-6 | | Amberlite GT73hydrogen form | | | | |
| 1138343-10-8 | 替加环素杂质1 | tigecycline impurity 1 | | | | |
| 113835-03-3 | | hr 3 | | | | |
| 113840-08-7 | 三乙基甲基甲基碳酸铵 溶液 | triethylmethylammonium methyl carbonate solution | | | | |
| 113842-31-2 | | 4-(4-bromophenyl)-1-buten-4-ol | | | | |
| 113844-47-6 | | A7 | C24H31ClO3 | 402.95 | | |
| 1138443-83-0 | | 3-iodo-5-methyl-1h-pyrrolo[2,3-b]pyridine | | | | |
| 1138443-84-1 | | 5-methoxy-n-phenylnicotinamide | | | | |
| 1138443-85-2 | | 5-bromo-2-((tert-butyldimethylsilyloxy)methyl)-3-methoxypyridine | | | | |
| 1138443-86-3 | | 5-bromo-2-(dimethoxymethyl)-3-methoxypyridine | | | | |
| 1138443-87-4 | | 6-((tert-butyldimethylsilyloxy)methyl)-2,3-dimethoxypyridine | | | | |
| 1138443-89-6 | | (5,6-dimethoxypyridin-3-yl)methanol | | | | |
| 1138443-91-0 | | 3-(dimethoxymethyl)-5-methoxy-4-(trimethylsilyl)pyridine | | | | |
| 1138443-93-2 | | 5,6-dimethoxynicotinaldehyde oxime | | | | |
| 1138443-95-4 | | 5,6-dimethoxypicolinaldehyde oxime | | | | |
| 1138443-96-5 | | tert-butyl (5-bromo-3-methoxypyridin-2-yl)methylcarbamate | | | | |
| 1138443-97-6 | | 5-(dimethoxymethyl)-2,3-dimethoxypyridine | | | | |
| 1138443-99-8 | | methyl 3-(5-bromo-3-methoxypyridin-2-yl)acrylate | | | | |
| 1138444-01-5 | | 2-chloro-4-iodo-3-(trimethylsilyl)pyridine | | | | |
| 1138444-02-6 | | (1-(5-bromo-3-nitropyridin-2-yl)pyrrolidin-3-yl)methanol | | | | |
| 1138444-04-8 | | 5-iodo-2,3-dimethoxypyridine | | | | |
| 1138444-05-9 | | n-(2,5-dibromopyridin-3-yl)pivalamide | | | | |
| 1138444-06-0 | | 2-bromo-5-iodopyridin-3-amine | | | | |
| 1138444-07-1 | | 4-iodo-5-methoxynicotinonitrile | | | | |
m.cnreagent.com